Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care
NCT ID: NCT01639586
Last Updated: 2023-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
360 participants
INTERVENTIONAL
2011-08-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the frame of non drug related approaches to Alzheimer disease (AD), several research projects and actions have already been conducted, but no specific study concerning the efficiency of different types of respite care structures have been conducted so far in France. The present project concerns the thematic of the frame "Development and diversification of respite care structures".
A platform is defined in the Alzheimer Plan as a "diversified range of despite structures according to patients' needs and informal caregivers' expectations" providing several objectives:
Two objectives targeting the informal caregivers:
* offer spare time or tutored
* inform, support and accompany
Two objectives targeting the patients:
* encourage maintain of the patient social life and relationships and work together towards his/her psychological and emotional well-being
* contribute to improve functional cognitive and sensory capacities
The study COMPARSE suggests to compare for the patient - informal caregiver couple, the impact of three different groups of patient care on health profit; resit platform (P), the day care group (D), the control group without access to a respite structure (C).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program
NCT02802371
Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
NCT00147693
Alzheimer's Disease, Art and Garden
NCT02208193
Effectiveness of Care Management in Alzheimer Patients
NCT01081743
Alzheimer Disease : Rehabilitation's Intervention at Home
NCT01689948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
D
Impact of the day care on health profit of patient
Day care
Impact of the day care on health profit of patient
C
No access to a respite structure
No access to a respite structure
Control group without access to a respite structure
B
Respite platform
respite platform
Impact of the respite platform patient care on health profit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
respite platform
Impact of the respite platform patient care on health profit
Day care
Impact of the day care on health profit of patient
No access to a respite structure
Control group without access to a respite structure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with an informal caregiver
* patient not using any respite structure
* signed informed consent (patient and informal caregiver)
* affiliate to social security
Exclusion Criteria
* patient include in another clinical protocol
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Clinical Research and Innovation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Clinical Research and Innovation
Department of Clinical Research and Innovation (drc)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Pradier, PHD MD
Role: PRINCIPAL_INVESTIGATOR
Département de Santé Publique - CHU de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Le Duff
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00167-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.